nicotine has been researched along with glyceryl 2-arachidonate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Cascio, MG; Di Marzo, V; Fernández-Ruiz, J; Fezza, F; González, S; Ramos, JA | 1 |
Astarita, G; Caprioli, G; Ciccocioppo, R; Cippitelli, A; Duranti, A; Kallupi, M; Piomelli, D; Rodrìguez de Fonseca, F; Sagratini, G; Stopponi, S; Ubaldi, M | 1 |
Melis, M; Pistis, M | 1 |
Buczynski, MW; Chang, JW; Cravatt, BF; Herman, MA; Hsu, KL; Irimia, C; Natividad, LA; Niphakis, MJ; Parsons, LH; Polis, IY; Pugh, H; Roberto, M | 1 |
Berrendero, F; Busquets-Garcia, A; de la Torre, R; Di Marzo, V; Flores, Á; Maldonado, R; Marsicano, G; Ozaita, A; Pastor, A; Plaza-Zabala, A; Saravia, R | 1 |
Akinola, LS; Cravatt, BF; Damaj, MI; Lichtman, AH; Mahadevan, A; Muldoon, PP; Schlosburg, JE; Sim-Selley, LJ | 1 |
1 review(s) available for nicotine and glyceryl 2-arachidonate
Article | Year |
---|---|
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons.
Topics: Animals; Arachidonic Acids; Dopamine; Dopaminergic Neurons; Endocannabinoids; Glycerides; Humans; Mesencephalon; Motivation; Nervous System Diseases; Nicotine; Receptor, Cannabinoid, CB1; Receptors, GABA; Reward; Substance-Related Disorders; Synaptic Transmission | 2012 |
5 other study(ies) available for nicotine and glyceryl 2-arachidonate
Article | Year |
---|---|
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
Topics: Animals; Arachidonic Acids; Binding Sites; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cocaine; Endocannabinoids; Ethanol; Glycerides; In Situ Hybridization; Male; Nicotine; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger; Substance-Related Disorders | 2002 |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
Topics: Acute Disease; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cotinine; Endocannabinoids; Glycerides; Implants, Experimental; Locomotion; Male; Maze Learning; Nicotine; Polyunsaturated Alkamides; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Weight Gain | 2011 |
Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure.
Topics: Animals; Arachidonic Acids; Endocannabinoids; gamma-Aminobutyric Acid; Glycerides; Lipoprotein Lipase; Male; Nicotine; Rats; Rats, Wistar; Self Administration; Ventral Tegmental Area | 2016 |
CB
Topics: Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Antagonists; Endocannabinoids; GABAergic Neurons; Glycerides; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyramidal Cells; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, GABA; Recognition, Psychology; Rimonabant; Substance Withdrawal Syndrome | 2017 |
Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
Topics: Animals; Anti-Anxiety Agents; Arachidonic Acids; Benzodioxoles; Cannabinoid Receptor Agonists; Conditioning, Classical; Endocannabinoids; Enzyme Inhibitors; Glycerides; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Monoacylglycerol Lipases; Nicotine; Piperidines; Receptor, Cannabinoid, CB1; Reward; Tobacco Use Disorder | 2020 |